Blood cancer patients with COVID-19 fare better with convalescent plasma
(Washington University in St. Louis) A large, retrospective, multicenter study involving Washington University School of Medicine in St. Louis indicates that convalescent plasma from recovered COVID-19 patients can dramatically improve likelihood of survival among blood cancer patients hospitalized with the virus. The therapy involves transfusing plasma -- the pale yellow liquid in blood that is rich in antibodies -- from people who have recovered from COVID-19 into patients who have leukemia, lymphoma or other blood cancers and are hospitalized with the viral infection. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2021 Category: Cancer & Oncology Source Type: news
KIYATEC clinical study data shows test accurately predicts brain cancer patient response
(MacDougall Biomedical Communications, Inc.) KIYATEC announces clinical study data showing test accurately predicts brain cancer patient response to standard drug therapy prior to treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2021 Category: Cancer & Oncology Source Type: news
Convalescent plasma improves survival in COVID-19 patients with blood cancers
(University of Texas Health Science Center at San Antonio) Patients with blood cancers who were hospitalized with COVID-19 fared better if they were given convalescent plasma, according to study findings from a consortium that included the Mays Cancer Center, home to UT Health San Antonio MD Anderson. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2021 Category: Cancer & Oncology Source Type: news
Most cancer cells grown in a dish have little in common with cancer cells in people
(Johns Hopkins Medicine) In a bid to find or refine laboratory research models for cancer that better compare with what happens in living people, Johns Hopkins Medicine scientists report they have developed a new computer-based technique showing that human cancer cells grown in culture dishes are the least genetically similar to their human sources. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2021 Category: Cancer & Oncology Source Type: news
Red meat consumption may promote DNA damage-assoc. mutation in colorectral cancer patients
(American Association for Cancer Research) Genetic mutations indicative of DNA damage were associated with high red meat consumption and increased cancer-related mortality in patients with colorectal cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2021 Category: Cancer & Oncology Source Type: news
Simple urine test may help early detection of brain tumors
(Nagoya University) A recent study by Nagoya University researchers revealed that microRNAs in urine could be a promising biomarker to diagnose brain tumors. Their findings have indicated that regular urine tests could help early detection and treatment of brain tumors, possibly leading to improved patient survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 17, 2021 Category: Cancer & Oncology Source Type: news
A simple blood test to identify patients at risk of nonalcoholic fatty liver disease
(Osaka University) Researchers from Osaka University, along with international collaborators in Europe, have identified Thrombospondin-2 as a serum biomarker that confirms and stratifies the progressive complications of nonalcoholic fatty liver disease. This research may form the basis of a new noninvasive approach that can provide an early warning system for nonalcoholic steatohepatitis and advanced fibrosis and may predict progression to cirrhosis, liver failure and even cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 16, 2021 Category: Cancer & Oncology Source Type: news
Survival among adults with early-onset colorectal cancer
(JAMA Network) Survival among people with early-onset (diagnosed before age 50) colorectal cancer compared with later-onset colorectal cancer (diagnosed at ages 51 through 55) was compared using data from the National Cancer Database. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 16, 2021 Category: Cancer & Oncology Source Type: news
Early lung cancer coopts immune cell into helping tumors invade the lungs
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Immune cells that normally repair tissues in the body can be fooled by tumors when cancer starts forming in the lungs and instead help the tumor become invasive, according to a surprising discovery reported by Mount Sinai scientists in Nature in June. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 16, 2021 Category: Cancer & Oncology Source Type: news
Intestinal cancers: The 14-3-3sigma gene acts as a tumor suppressor
(Ludwig-Maximilians-Universit ä t M ü nchen) LMU researchers have identified the 14-3-3sigma gene as an important suppressor of carcinogenesis in the gastrointestinal tract. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 16, 2021 Category: Cancer & Oncology Source Type: news
MD Anderson research highlights for June 16, 2021
(University of Texas M. D. Anderson Cancer Center) The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a new combination therapy for acute myeloid leukemia (AML), a greater understanding of persistent conditions after AML remission, the discovery of a universal biomarker for exosomes, the identification of a tumor suppressor gene in hepatocellular carcinoma (HCC) and characterization of a new target to treat Clostridioides difficile (C. difficile) inf...
Source: EurekAlert! - Cancer - June 16, 2021 Category: Cancer & Oncology Source Type: news
PSMA-targeted radiotracer pinpoints metastatic prostate cancer across anatomic regions
This study was presented at the SNMMI 2021 Annual Meeting. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
Financial distress similar, or greater, for patients with heart disease compared to cancer
(American College of Cardiology) Financial toxicity, the financial strain experienced by patients accessing health care, impacts a large population of cancer patients according to prior research. A new study, published in JACC: CardioOncology, finds financial toxicity is often greater among heart disease patients compared to cancer patients, and those with both conditions suffer the highest burden. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
Pew supports 22 scientists exploring innovative solutions to biomedical challenges
(Pew Charitable Trusts) The Pew Charitable Trusts today announced that 22 early-career researchers have been selected to join the Pew Scholars Program in the Biomedical Sciences. These scientists will receive funding over the next four years as they investigate timely questions surrounding human health and disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
Pew funds 10 Latin American scientists conducting critical biomedical research
(Pew Charitable Trusts) The Pew Charitable Trusts today announced the 2021 class members of the Pew Latin American Fellows Program in the Biomedical Sciences. The 10 postdoctoral fellows from six Latin American countries--Argentina, Brazil, Chile, Mexico, Peru, and Uruguay--will receive two years of funding to conduct research in laboratories across the United States and will work under the mentorship of prominent biomedical scientists, including members of the Pew Scholars Program in the Biomedical Sciences. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 15, 2021 Category: Cancer & Oncology Source Type: news
